
Blood Pressure Drug Reviewed after Cancer-Causing Causing Substance Found
A pharmaceutical organization is intentionally reviewing blood pressure prescription in the wake of distinguishing follow measures of a cancer-causing causing substance. Torrent Pharmaceuticals Limited reported the review for two heaps of Losartan potassium tablets on the FDA (United States Food…